Biophage awarded government accreditation for its Beryllium reference lab

13-Sep-2007

Biophage Pharma Inc. announced that it has obtained official accreditation from the Quebec Ministry of Health and Social services for its beryllium Reference Laboratory. According to the company, this certification makes Biophage the only officially recognized lab qualified to conduct government approved screening for Beryllium sensitization (BeLPT testing) in Quebec. Biophage secured the certification by meeting strict government guidelines and demonstrating its competence in the analysis and interpretation of BeLPT test results.

The Quebec CSST survey entitled "Operation Beryllium" confirmed that Beryllium is present in 2800 establisments in Quebec with a potential 100,000 beryllium exposed workers. In the United States, several studies reported that around 800,000 workers were exposed to Beryllium. The major sectors are foundries, aerospace and aeronautics sector, machine shops and scrap metal shops, dentistry labs and recycling industries. It is also known that family members of Beryllium exposed workers are also at risk of secondary exposure to Beryllium dust brought home from the workplace on clothing.

"This accreditation represents a significant milestone for Biophage and puts us in the front seat far ahead of competition. It will also help us accelerate the generation of revenues from this very lucrative market that represents about $35 million in Quebec and $1.2 billion in the United States." said Dr. Rosemonde Mandeville, President and Chief Executive Officer of Biophage Pharma Inc. "Our objective is to reach the largest number of workers in the aerospace industries and foundries in Canada and the United States, so that they can benefit from this screening as quickly as possible," concluded Dr. Mandeville.

https://www.bionity.com/en/news/69670/biophage-awarded-government-accreditation-for-its-beryllium-reference-lab.html